BIOTECH

Travecta Therapeutics Announces It Has Closed Its Oversubscribed Series A Round At $27 Million

BIOTECH

Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million
June 11, 2020

NEW YORK and SINGAPORE – June 11, 2020 – Travecta Therapeutics, a biopharmaceutical company pioneering...

Read more
Sgi Portfolio Logo Travecta

BIOTECH

Travecta Therapeutics Secures $15 Million in Financing
May 12, 2020

NEW YORK and SINGAPORE – May 12, 2020 – Travecta Therapeutics, a biopharmaceutical company developing...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept